Tweet
I am using targeted sequencing designed by Qiagen. I would like to perform a gel run for my samples before measuring them by Qubid and AMPure step. The reason I want to do that is because if I depended ONLY on Qubid I will have a measurement for everything in my sample, while when I run a gel I can see my targeted amplicons based on their size in the gel. Does any one agree with me? if disagree can you tell me why and correct me if I am wrong?
-
-
With a normal ampure cleanup you can get rid of primers. Depending on exactly what you are doing you can do some size selection as well. Typically people will use a bioanalyzer or a tapestation as a final step to QC their library and to quantify it. If you do a gel extraction first you can lose a lot of material and possibly sacrifice the complexity of your library. -
Thank you for your replay. I want to use the gel just to check the (efficiency) of my PCR that is all. I will not cut it or size select. This is becasue when I measure with quibid I get reading that is much higher than after AMPure which is a very tuff experiance for my sample
as they end up with much lower reading after the AMPure. So I do not know if this low reading becasue my PCR was not working well from the begining or a result of the AMPure step.
Comment
-
Ah, if you're just troubleshooting then go for it. Then you can determine if the problem is the PCR or the Ampure cleanup.Comment
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment